COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,831 Articles (22,553 medRxiv, 8,278 bioRxiv)

Most recent first Previous |  Page 1681: Articles 16801-16810  | Next

Therapeutic Anticoagulation in Critically Ill Patients with Covid-19-Preliminary Report
Goligher, E. C., Bradbury, C. A., McVerry, B. J., Lawler, P. R., Berger, J. S., Gong, M. N., Carrier, M., Reynolds, H. R., Kumar, A., Turgeon, A. F., Kornblith, L. Z., Kahn, S. R., Marshall, J. C., Kim, K. S., Houston, B. L., Derde, L. P. G., Cushman, M., Tritschler, T., Angus, D. C., Godoy, L. C., McQuilten, Z., Kirwan, B.-A., Farkouh, M. E., Brooks, M. M., Lewis, R. J., Gordon, A., Berry, S., McArthur, C. J., Neal, M. D., Hochman, J. S., Webb, S. A., Zarychanski, R.
10.1101/2021.03.10.21252749 — Posted: 2021-03-12
Rapid screening for SARS-CoV-2 variants of concern in clinical and environmental samples using nested RT-PCR assays targeting key mutations of the Spike protein
La Rosa, G., Mancini, P., Bonanno Ferraro, G., Veneri, C., Iaconelli, M., Lucentini, L., Bonadonna, L., Brusaferro, S., Brandtner, D., Fasanella, A., Pace, L., Parisi, A., Galante, D., Suffredini, E.
10.1101/2021.03.09.21252450 — Posted: 2021-03-12
Efficacy of SARS-CoV-2 Repeat Testing to Control Spread in Residential College Populations
Hambridge, H. L., Kahn, R., Onnela, J.-P.
10.1101/2021.03.09.21253198 — Posted: 2021-03-12
Detection of SARS-CoV-2 lineage P.1 in patients from a region with exponentially increasing hospitalization rates in February 2021, Rio Grande do Sul, Southern Brazil
Martins, A. F., Zavascki, A. P., Wink, P. L., Volpato, F. C. Z., Monteiro, F. L., Rosset, C., de-Paris, F., Ramos, A. K., Barth, A. L.
10.1101/2021.03.09.21253204 — Posted: 2021-03-12
A Recovery Algorithm and Pooling Designs for One-Stage Noisy Group Testing under the Probabilistic Framework
Liu, Y., Kadyan, S., Pe'er, I.
10.1101/2021.03.09.21253193 — Posted: 2021-03-12
An In-House ELISA for SARS-CoV-2 RBD uncovers elevatedimmune response at higher altitudes
Tomas Grau, R., Ploper, D., Avila, C. L., Vera Pingitore, E., Maldonado, C., Chaves, S., Socias, S. B., Stagnetto, A., Navarro, S., Chahla, R., Aguilar, M., Llapur, C., Aznar, P., Alcorta, M., Costas, D., Flores, I., Apfelbaum, G., Heinze, D., Mostoslavsky, R., Mostoslavsky, G., Perdigon, G., Cazorla, S., Chehin, R.
10.1101/2021.03.10.21252711 — Posted: 2021-03-12
Analytical and clinical performances of a SARS-CoV-2 S-RBD IgG assay: comparison with neutralization titers
Padoan, A., Bonfante, F., Cosma, C., Di Chiara, C., Sciacovelli, L., Pagliari, M., Bortolami, A., Costenaro, P., Musso, G., Basso, D., Plebani, M.
10.1101/2021.03.10.21253260 — Posted: 2021-03-12
Global association of obesity and COVID-19 death rates
Adams, M. L.
10.1101/2021.03.09.21253222 — Posted: 2021-03-12
Higher viral load drives infrequent SARS-CoV-2 transmission between asymptomatic residence hall roommates
Bjorkman, K. K., Saldi, T. K., Lasda, E., Conners Bauer, L., Kovarik, J., Gonzales, P. K., Fink, M. R., Tat, K. L., Hager, C. R., Davis, J. C., Ozeroff, C. D., Brisson, G. R., Larremore, D. B., Leinwand, L. A., McQueen, M. B., Parker, R.
10.1101/2021.03.09.21253147 — Posted: 2021-03-12 Discussion: Offsite
The Value of Rapid Antigen Tests to Identify Carriers of Viable SARS-CoV-2.
Shidlovskaya, E. V., Kuznetsova, N. A., Divisenko, E. V., Nikiforova, M. A., Siniavin, A. E., Ogarkova, D. A., Shagaev, A. V., Semashko, M. A., Tkachuk, A. P., Burgasova, O. A., Gushchin, V. A.
10.1101/2021.03.10.21252667 — Posted: 2021-03-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).